Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aloxi incorporated in NCCN antiemetic guidelines for CINV

March 18, 2004

TopoTarget and deCODE collaborate on improved cancer treatments

March 18, 2004

Targeting telomerase for multiple myeloma therapy

March 18, 2004

Submission of final section of Onco TCS rolling NDA

March 17, 2004

European approval for Faslodex

March 17, 2004

XL-119 receives orphan drug status for bile duct tumors

March 17, 2004

FDA Advisory Committee sets date to review RSR-13 NDA

March 17, 2004

New alphav integrin inhibitors and their use reported by Sigma-Tau

March 17, 2004

Biomar presents a novel cytotoxic agent isolated from fungal cultures

March 17, 2004

Geron and Merix enter coexclusive license agreement for cancer vaccines

March 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...